ArticleOncotarget2016

MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cells.

Zhihong Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.